Venture Capital Companies in BioPortfolio's Corporate Database - Page: 2 
Venture Capital company data on BioPortfolio. Our corporate data records list over 50,000 company records. Here you can see the latest Venture Capital companies that have been added to our BioPortfolio's life-science corporate directory.
Search For More Venture Capital Companies
If you don't find the company you're looking for in the list below, you may wish to search our extensive database for further matches: Search for More Venture Capital Companies.
More Information about Venture Capital on BioPortfolio
We have published hundreds of Venture Capital news stories on BioPortfolio along with dozens of Venture Capital Clinical Trials. In addition to the corporate data, news and clinical trials, BioPortfolio also has a large collection of PubMed Articles about Venture Capital for you to read.
Showing "venture capital" Companies 26 to 50 of 1,400+
MedPanel, Inc., a global organization based in Cambridge, MA, was founded in 1999 by three people determined to bring a unique approach to gathering information from medical professionals. Brothers William and Phillip Febbo, MD, and a friend, Ian Edgar, set out to build the platform, medical community, and client list that would allow for quick, unbiased, affordable research between physicians and...
Healthcare - A Quickly Expanding Market Healthcare is a significant and growing portion of the U.S. economy. U.S. expenditures are predicted to out-pace the broader economy and to top $4 trillion by the year 2015. With those figures in mind, NEA has significantly added to and strengthened its healthcare investing team in recent years. NEA believes that the healthcare sector will offer outstandi...
In the biotechnology industry where the creation of any start-up depends on the input of the investors and on the fluctuations of the stock market, Covalab stands out as an exception. Indeed, with a minimum of initial capital and the assistance of University Claude Bernard (Lyon), the company developed slowly using as its foundation its know-how in Immunochemistry. The principal aim of its...
Kilmer Lucas is an independent investor relations and corporate communications agency serving the needs of public and pre-public companies in both Canada and the United States. We are differentiated in three important ways. First, while we feel equally comfortable working on both sides of the border, we have had unique success in helping Canadian and other non-U.S. issuers to navigate and penetrat...
About Orla Orla Protein Technologies Ltd is a privately owned company based in Newcastle, UK. Its key assets are its protein and biosurface expertise, including protein design and manufacture, for biosurface applications. The company has a range of patented, fully-owned technologies that are used to provide bespoke solutions in these fields. Orla also has a joint-venture company, OJ Bio, in p...
Forbion Capital Partners is a Netherlands-based venture capital firm focused on investing in life sciences companies in drug development as well as MedTech companies addressing high medical needs. Forbionâs investment team of nine investment professionals has built an impressive performance track record since the late nineties with successful investme...
Gleacher & Company, Inc. (Nasdaq: GLCH) is an independent, full service investment bank that provides corporate and institutional clients with strategic, research-based investment opportunities, capital raising, and financial advisory services, including merger and acquisition, restructuring, recapitalization, and strategic alternative analysis, as well as...
Irving Place Capital invests private equity capital in buyouts, recapitalizations, and growth capital opportunities alongside superior management teams. Irving Place Capital focuses on making control or entrepreneur-driven investments. Since its formation in 1997, Irving Place Capital has been an investor in more than 50 companies and has raised over $4.0...
Stromedix is a privately held biotechnology company based in Cambridge, Massachusetts, focused on innovative therapies for fibrotic organ failure. Investors in Stromedix include Atlas Venture, New Leaf Venture Partners, Frazier Healthcare Ventures, Bessemer Venture Partners and Red Abbey Venture Partners. Biogen Idec is also a shareholder. For more informa...
National Investment Banking Association (NIBA)
NIBA is the only national not-for-profit trade association of regional and independent brokerages, investment banking firms, institutional investors and related capital market service providers. Since its inception, NIBA member firms have successfully completed nearly 1000 equity offerings totaling approximately $10 billion in new capital for America's fin...
AckerleyLDA is a joint venture of two award winning San Francisco based architectural firms. AckerleyLDA specializes in providing planning, design, and interior architecture services for the health care industry, which includes hospitals, biotech clean facilities, medical office buildings, nursing homes, and special care facilities.
Named on AdWeek Mediaâs 2010 OOH Hot List, RMG is a digital media company that owns, operates and powers place-based video networks that reach active consumers across multiple high-engagement media platforms. Its In-Flight Entertainment, Fitness Entertainment, Point-of-Care, mtvU and NYTimes.com Today networks engage 45 million highly desirable and el...
Solazyme, Inc. is a renewable oil and bioproducts company and the leader in algal biotechnology. Founded in 2003 and headquartered in South San Francisco, Solazymeâs unique technology allows algae to produce oil and biomaterials in standard fermentation facilities quickly, efficiently and at large scale. These oils and biomaterials are tailored not only...
Arcapita is a global investment bank headquartered in Bahrain with offices in Atlanta, London and Singapore, and operates across four lines of business: Corporate Investment, Real Estate Investment, Asset-Based Investment and Venture Capital. Since its foundation in 1997, Arcapita has completed more than 71 transactions with a total value of approximately...
Vestar Capital Partners V, L.P.
Vestar Capital Partners is a leading global private equity firm with more than 22 years of experience investing in middle-market companies with $7Â billion in assets currently under management. From its headquarters in New York, and through its five offices in the U.S. and Europe, Vestar employs its value-oriented investment approach across a variety of...
Relypsa, Inc. is a, clinical-stage biopharmaceutical company leading the discovery and development of novel non-absorbed polymeric drugs for important applications in cardiovascular and renal diseases. Relypsa's lead product candidate is RLY5016, a non-absorbed potassium binder for the treatment of hyperkalemia. Relypsa is dedicated to the discovery of add...
TowerBrook Capital Partners, L.P.
TowerBrook Capital Partners L.P. is an investment management firm with approximately $5 billion of capital under management. With offices in New York, London and San Francisco, the firm focuses on making investments in North American and European companies. TowerBrook primarily pursues control-oriented private equity investments in large and middle market...
Itero Biopharmaceuticals, Inc.
Itero Biopharmaceuticals, Inc. is a specialty biopharmaceutical company focused on the development and commercialization of protein therapeutics that offer significant clinical and commercial advantages over currently marketed alternatives. Itero is led by an executive team with 100+ collective years of successful experience in the development, manufacturi...
Trilantic Capital Partners is a private equity firm focused on control and significant minority investments in North America and Europe with primary investment focus in consumer, energy, financial and business services. Trilantic was formed in 2009 by the former principals of Lehman Brothers Merchant Banking, where they created a strong track record of inv...
DecImmune Therapeutics was founded by Michael Carroll PhD (The Immune Disease Institute, Harvard Medical School), and Francis Moore Jr. MD (Brigham and Womenâs Hospital, Harvard Medical School). Drs. Moore and Carroll discovered the epitope of non-muscle myocin heavy chain II (âN2â) that becomes exposed on vascular cells during hypoxia. During...
Integra Telecom Inc. provides integrated communications services across 33 metropolitan areas in 11 Western states, including: Arizona, California, Colorado, Idaho, Minnesota, Montana, Nevada, North Dakota, Oregon, Utah and Washington. It owns and operates a best-in-class fiber-optic network comprising more than 2,800 route miles in 11 metropolitan access...
Crocker Ventures (www.crockerventures.com) is an independent, privately-held life science and healthcare investment firm that funds promising seed- and early-stage life science technology companies in four primary areas: diagnostics, biotechnology/pharmaceuticals, drug delivery, and medical devices. We are committed to identifying companies with strong int...
Spring Creek Healthcare Systems, Inc.
Spring Creek Healthcare Systems, Inc. (formerly Spring Creek Capital Corp.) is a healthcare solutions company whose business plan is to distribute cutting edge solutions for the medical, pharmaceutical and healthcare markets to resellers and consumers worldwide. Spring Creek actively pursues emerging opportunities in the healthcare industry by selecting yo...
Mid-Atlantic Bio â taking place September 27-28 in Bethesda, Md. â is one of the countryâs premier biotech conferences for senior-level executives, policymakers, academia, financiers, media and service providers. Its proximity to the US government, federal labs, commercial research and development, academic centers of excellence and a growing...
BioRelix, Inc, is a drug discovery and development company focused on identifying new anti-infective drug treatments. BioRelix is building a portfolio of anti-infective products based on novel patented RNA targets, termed riboswitches, which were identified by the laboratory of BioRelix co-founder, Ronald Breaker, Ph.D., Howard Hughes Investigator and Henr...
